AnGes: Interim Report

EDINETMar 30 00:33 ET · Announcements

Anges makes steady progress toward the planned 2027 market launch of its HGF gene therapy product.

Anges (<4563>), a biotech venture originating from Osaka University, was established in 1999. The company envisions becoming a global leader in genetic medicine, bringing innovation to diseases that still lack effective treatments and contributing to the improvement of QOL (quality of life) for people worldwide. In 2020, Anges acquired EmendoBio Inc., a developer of advanced genome-editing technologies, as a subsidiary. Additionally, in 2021, the company launched expanded newborn screening programs targeting rare genetic disorders within Japan.

Fisco JapanMar 25 21:46 ET

Five companies included disclosures, while seven companies deferred—pertaining to the going concern assumption in notes, as of the 25th business report submission.

As of the securities reports and semi-annual reports submitted on March 25, five listed companies included a note regarding the going concern assumption due to the presence of events or circumstances that raise significant doubts about the continuation of their business activities. The companies in question are as follows: ▽Securities Report <3664> Mobcast HD FY2025/12, <3667> enish FY2025/12, <4563> Anges FY2025/12, <6612> Balミューダ FY2025/12, <8165> Sentique FY2025/12.

Jiji PressMar 25 21:01 ET

AnGes: Confirmation letter

EDINETMar 24 21:09 ET · Announcements

Audit Consideration 25/12 - Anges: Evaluation of raw materials for HGF gene therapy product

Submitter: <4563> AnGes Inc., Submission Date and Time: March 25, 2026, 10:06 AM, Submitted Document: Annual Securities Report, Fiscal Year: 27th Term (From January 1, 2025, to December 31, 2025) <Key Audit Matters for Consolidated Financial Statements: 1 Item> ▼ Evaluation of Raw Materials for HGF Gene Therapy Product <First Two Sentences> As stated in the notes to the consolidated financial statements (critical accounting estimates), raw materials amounting to JPY 1,354,298 thousand.

Jiji PressMar 24 21:09 ET

AnGes: Securities Report – 27th Fiscal Period (January 1, 2025 – December 31, 2025)

EDINETMar 24 21:06 ET · Announcements